Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / SHS CL A
-
Total 13F shares
-
33,452,097
-
Share change
-
+32,922,683
-
Total reported value
-
$80,954,450
-
Put/Call ratio
-
358%
-
Price per share
-
$2.42
-
Number of holders
-
55
-
Value change
-
+$79,786,219
-
Number of buys
-
52
-
Number of sells
-
5
Institutional Holders of PROKIDNEY CORP. - SHS CL A (PROK) as of Q3 2025
As of 30 Sep 2025,
PROKIDNEY CORP. - SHS CL A (PROK) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,452,097 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Bleichroeder LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, Hennion & Walsh Asset Management, Inc., BANK OF AMERICA CORP /DE/, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.